CAMRF
CAMURUS AB by Camurus AB (CAMRF)
$00
About CAMURUS AB by Camurus AB (CAMRF)
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Details
Daily high
$55.00
Daily low
$55.00
Price at open
--
52 Week High
$71.07
52 Week Low
$52.31
Market cap
3.3B
Dividend yield
0.00%
Volume
60
Avg. volume
11
P/E ratio
43.60
CAMURUS AB by Camurus AB News
Details
Daily high
$55.00
Daily low
$55.00
Price at open
--
52 Week High
$71.07
52 Week Low
$52.31
Market cap
3.3B
Dividend yield
0.00%
Volume
60
Avg. volume
11
P/E ratio
43.60